Drug intelligence / Profile preview

Autologous umbilical cord blood cells

Development stage
Unknown
Lead developer
Duke University
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Autologous umbilical cord blood (UCB) cells are an experimental cell therapy being investigated for the treatment of neonates with hypoplastic left heart syndrome (HLHS). Developed by researchers at Duke University, the therapy involves the collection and subsequent intravenous infusion of the patient's own volume-reduced cord blood cells. The therapeutic rationale is based on the potential for UCB cells to mitigate neural and cardiac injury through paracrine and anti-inflammatory effects. Specifically, the infusion is intended to lessen neural injury common in HLHS patients and enhance cardiac function by minimizing scar formation and reversing detrimental remodeling following surgical intervention.

Other names
Autologous umbilical cord bloodAutologous UCB

Beyond the preview

Go deeper on Autologous umbilical cord blood cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autologous umbilical cord blood cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call